Mokaddem A, Chattaoui R, Sdiri W, Kachboura S, Boujnah M R
Service de cardiologie, Hôpital Mongi Slim La Marsa.
Tunis Med. 2001 Nov;79(11):569-73.
The Brugada syndrome is a clinical-electrocardiographic diagnosis characterised by syncopal or sudden death episodes in patients with a structurally normal heart with a characteristic electrocardiographic pattern consisting of ST segment elevation in the precordial leads V1 to V3 and a morphology of the QRS complex resembling a right bundle branch block. In many patients with the Brugada syndrome, the electrocardiographic manifestations transiently normalize; leading to underdiagnosis of the syndrome. The administration of sodium channel blockers such as ajmaline, flecainide or procainamide accentuate the ST segment elevation and can be used to unmask concealed and intermittent forms of the disease. The incidence of sudden death in this syndrome is very high and can only be prevented by implanting a cardioverter-defibrillator. Because of high incidence of familial occurrence, the extension of the testing to family members is important.
Brugada综合征是一种临床心电图诊断,其特征为结构正常的心脏患者出现晕厥或猝死发作,伴有特征性心电图模式,包括胸前导联V1至V3的ST段抬高以及QRS波群形态类似右束支传导阻滞。在许多Brugada综合征患者中,心电图表现会短暂恢复正常,导致该综合征诊断不足。使用钠通道阻滞剂如阿义马林、氟卡尼或普鲁卡因胺可使ST段抬高加重,可用于揭示该疾病的隐匿和间歇性形式。该综合征的猝死发生率非常高,只能通过植入心脏复律除颤器来预防。由于家族性发病的发生率很高,对家庭成员进行检测很重要。